Search
Search Results
##search.searchResults.foundPlural##
-
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1731PDF: 638HTML: 288 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2662PDF: 978HTML: 594 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1167PDF: 916HTML: 292 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3569PDF: 1430HTML: 2722 -
-
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
891PDF: 497HTML: 1312 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4584PDF: 3761HTML: 374 -
-
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1581PDF: 931HTML: 384 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3877PDF: 1539HTML: 347 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1608PDF: 941HTML: 2010Figure: 197Tables: 208ALL revision 1: 292response to reviewer: 201 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4870PDF: 1603HTML: 2267Untitled: 252Untitled: 266Untitled: 286Untitled: 236Untitled: 253 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3779PDF: 1341HTML: 2168Fig.1: 238Fig. 2: 232 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4482PDF: 1804HTML: 1124 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1952PDF: 1205HTML: 337 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
1028PDF: 588HTML: 2224Cover Letter: 216 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2649PDF: 1223HTML: 283 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3798PDF: 936HTML: 6876 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
765PDF: 482HTML: 6282 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3607PDF: 920HTML: 1689figure 1: 189Untitled: 212 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2509PDF: 1640HTML: 706 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3459PDF: 1370HTML: 6344 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2219PDF: 867HTML: 1650Figure 1: 574 -
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE IN EGYPTIAN CHILDREN
3423PDF: 902HTML: 1165Cover: 205 -
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3304PDF: 948HTML: 779text and figure: 248 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1384PDF: 1000HTML: 443







